| North Bridge Podiatry Group, P.c. | |
|
1732 Main St, Concord, MA 01742-3837 | |
| (978) 369-2665 | |
| (978) 371-9914 |
| Full Name | North Bridge Podiatry Group, P.c. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Primary Podiatric Medicine |
| Location | 1732 Main St, Concord, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609831023 | NPI | - | NPPES |
| NOY77264 | Other | MA | BLUE SHIELD OF MA |
| 59939 | Other | MA | FALLON HEALTH PLAN |
| 667826 | Other | MA | TUFTS HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | MA1967 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| North Bridge Podiatry Group, P.c. 1732 Main St, Concord, MA 01742-3837 Ph: (978) 369-2665 | North Bridge Podiatry Group, P.c. 1732 Main St, Concord, MA 01742-3837 Ph: (978) 369-2665 |
News Archive
As the U.S. Food and Drug Administration is reviewing pivotal regulatory procedures for one of America's fastest growing sectors, industry leaders will gather to meet with lawmakers and government officials at the 16th Annual Meeting of the Medical Device Manufacturers Association on May 24-26, 2010 at the Park Hyatt in Washington, DC.
A clinical study conducted by scientists at British American Tobacco have revealed that when smokers switch completely from cigarettes to glo, their exposure to certain cigarette smoke toxicants is significantly reduced, in some cases to levels comparable to those seen in smokers who quit smoking completely.
A recently published study, conducted at the Gerontology Research Center of the University of Jyväskylä, found associations between features of natural environment in the home neighborhood and physical activity of older people.
Functional magnetic resonance imaging (fMRI) of the brain reduces the need for invasive testing of seizure disorder patients being considered for surgical treatment, according to a study published in the July issue of the journal Radiology.
Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom (UK), Germany, Italy, France and Spain. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to U.S. dentists.
› Verified 1 days ago
Sarah Cantin-langlois, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 54 Baker Avenue Ext Ste 103, Concord, MA 01742 Phone: 978-369-5282 | |
Mass Assoc In Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 290 Baker Ave, Ste. N104, Concord, MA 01742 Phone: 978-369-5282 Fax: 978-369-2926 | |
Gregory D Catalano, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1732 Main St, Concord, MA 01742 Phone: 978-369-2665 Fax: 978-371-9914 | |
Sandra M Weakland Dpm,pc Podiatrist Medicare: Medicare Enrolled Practice Location: 290 Baker Ave, Suite N104, Concord, MA 01742 Phone: 978-369-5282 Fax: 978-369-2926 | |
Summer G Getzen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1732 Main St, Concord, MA 01742 Phone: 978-369-2665 Fax: 978-371-9914 | |
Dr. Alissa Kuizinas, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 54 Baker Avenue Ext Ste 301, Concord, MA 01742 Phone: 978-369-5282 Fax: 978-369-2926 |